Introduction: Lung cancer is the leading cause of cancer-related mortality globally. Despite
recent advances with personalized therapies and immunotherapy, the prognosis remains …

Emerging evidence has provided important information on oncoproteins involved in cancer
initiation, progression, metastasis, and resistance to current therapies. C-myc, one of the …

Sarcoidosis is a systemic inflammatory disease of unknown etiology. The pathogenesis rests
on an aberrant T cell response to unidentified antigens in individuals predisposed by …

The majority of cases involving hypercalcemia in the setting of sarcoidosis are explained by
the overproduction of calcitriol by activated macrophages. Vitamin D takes part in the …

Background The objective of this prospective study was to evaluate whether soluble
programmed cell death-1/programmed cell death-ligand 1 (PD-1/PD-L1) and serum amyloid …

Restrictive lung disease is defined as a reduction in lung volume that may be due to
intraparenchymal or extraparenchymal causes. Intraparenchymal causes falls under the …

Sarcoidosis is a systemic multisystem inflammatory disease of unknown etiology. The
disease is characterized by formation of non-caseating granulomas. The most common …

Background C-Myc is one of the major cellular oncogenes overexpressed in non-small cell
lung carcinoma (NSCLC). Its deregulated expression is necessary but not sufficient for …

Vitamin D covers roles of paramount importance in the regulation of multiple physiological
pathways of the organism. The metabolism of vitamin D involves kidney–liver crosstalk and …

Sarcoidosis is a systemic granulomatous disease with a variety of presentations. One of the
known symptoms are altered vitamin D metabolism and hypercalcemia. In our study, we …